Faun Pharma

Zinzino October Revenue Rises 1% to SEK 328.7 Million

GOTHENBURG – November 04, 2026 -- Zinzino's group revenue rose 1% in October to SEK 328.7 million, up from SEK 326.0 million a year earlier, as growth slowed sharply against the year-to-date pace.

Sales markets add 1% to reach SEK 325.1 million

Revenue from Zinzino's sales markets increased to SEK 325.1 million in October, compared with SEK 323.3 million in the prior-year month. The increase of SEK 1.8 million accounts for most of the group's monthly gain.

Faun Pharma external sales climb 33% to SEK 3.6 million

Faun Pharma's external sales rose to SEK 3.6 million from SEK 2.7 million. The unit remains small, contributing about 1% of group revenue for the month.

Zinzino Group Revenue Rises 15% to SEK 282.2M in August 2026

Gothenburg – – September 08, 2026 -- Zinzino AB reported group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million a year earlier, as growth in its direct-sales markets offset a sharp decline at subsidiary Faun Pharma.

Sales markets revenue climbs 16% to SEK 280.9 million in August

Zinzino's core direct-sales business generated SEK 280.9 million in August 2026, up from SEK 242.5 million in the same month last year, a 16% increase that drove the bulk of the group's top-line expansion.

Faun Pharma external sales drop to SEK 1.3 million from SEK 3.4 million

Faun Pharma's external sales fell to SEK 1.3 million in August 2026, down from SEK 3.4 million a year earlier, a decline that partially offset the stronger performance of Zinzino's sales markets and reduced the group's overall growth rate to 15% from the 16% posted by the sales markets alone.